CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-12 | Dworak Leiden Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +46,875 | 46,875 | ||
| 2024-01-12 | MacBeath Gavin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2023-12-19 | BARBERICH TIMOTHY J Director | Purchase | +317 | $4.97 | $2K | 67,027 |
| 2023-12-18 | BARBERICH TIMOTHY J Director | Purchase | +28,830 | $4.89 | $141K | 66,710 |
| 2023-12-14 | Klencke Barbara Director | Purchase | +5,000 | $5.08 | $25K | 30,000 |
| 2023-12-06 | Woods Keith Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2023-07-21 | Dworak Leiden Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-06-13 | BAKER BROS. ADVISORS LP Director | Grant or award · Non- Qualified Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2023-06-13 | BARBERICH TIMOTHY J Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2023-06-13 | Barton Debora Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +430,000 | 430,000 | ||
| 2023-06-13 | Dorton Katina Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2023-06-13 | Gruia Gabriela Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2023-06-13 | Klencke Barbara Director | Grant or award · Stock Option (Right to Buy) | +36,524 | 36,524 | ||
| 2023-06-13 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +632,500 | 632,500 | ||
| 2023-06-13 | MacBeath Gavin Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,121,300 | 1,121,300 | ||
| 2023-06-13 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +430,000 | 430,000 | ||
| 2023-06-02 | BARBERICH TIMOTHY J Director | Purchase | +37,880 | $2.63 | $100K | 37,880 |
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +3,192,710 | $2.00 | $6.4M | 3,192,710 |
| 2023-06-01 | BAKER BROS. ADVISORS LP Director | Grant or award · Warrants to purchase Common Stock | +34,307,290 | $2.00 | $68.6M | 34,307,290 |
Page 4 of 8 · 144 trades